7-45917251-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000598.5(IGFBP3):āc.592C>Gā(p.Gln198Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000149 in 1,613,966 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00011 ( 0 hom., cov: 32)
Exomes š: 0.00015 ( 1 hom. )
Consequence
IGFBP3
NM_000598.5 missense
NM_000598.5 missense
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 5.50
Genes affected
IGFBP3 (HGNC:5472): (insulin like growth factor binding protein 3) This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein forms a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08280349).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGFBP3 | NM_000598.5 | c.592C>G | p.Gln198Glu | missense_variant | 2/5 | ENST00000613132.5 | NP_000589.2 | |
IGFBP3 | NM_001013398.2 | c.610C>G | p.Gln204Glu | missense_variant | 2/5 | NP_001013416.1 | ||
IGFBP3 | XM_047420325.1 | c.592C>G | p.Gln198Glu | missense_variant | 2/4 | XP_047276281.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGFBP3 | ENST00000613132.5 | c.592C>G | p.Gln198Glu | missense_variant | 2/5 | 5 | NM_000598.5 | ENSP00000477772.2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152090Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
17
AN:
152090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000231 AC: 58AN: 251486Hom.: 0 AF XY: 0.000309 AC XY: 42AN XY: 135918
GnomAD3 exomes
AF:
AC:
58
AN:
251486
Hom.:
AF XY:
AC XY:
42
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000153 AC: 223AN: 1461758Hom.: 1 Cov.: 31 AF XY: 0.000168 AC XY: 122AN XY: 727190
GnomAD4 exome
AF:
AC:
223
AN:
1461758
Hom.:
Cov.:
31
AF XY:
AC XY:
122
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74404
GnomAD4 genome
AF:
AC:
17
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
74404
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
32
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2023 | The c.610C>G (p.Q204E) alteration is located in exon 2 (coding exon 2) of the IGFBP3 gene. This alteration results from a C to G substitution at nucleotide position 610, causing the glutamine (Q) at amino acid position 204 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;N;.;N
REVEL
Benign
Sift
Benign
D;.;T;T;.;D
Sift4G
Benign
T;T;T;T;T;T
Polyphen
P;.;B;.;.;.
Vest4
MVP
MPC
1.0
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at